Effect of celecoxib on Ca2+ fluxes and proliferation in MDCK renal tubular cells.
The effect of celecoxib on renal tubular cells is largely unexplored. In Madin Darby canine kidney (MDCK) cells, the effect of celecoxib on intracellular CaCa2+ concentration ([Ca2+]i) and proliferation was examined by using the Ca(2 +)-sensitive fluorescent dye fura-2 and the viability detecting fluorescent dye tetrazolium, respectively. Celecoxib (> or =1 micro M) caused an increase of [CaCa2+]i in a concentration-dependent manner. Celecoxib-induced [CaCa2+]i increase was partly reduced by removal of extracellular CaCa2+. Celecoxib-induced CaCa2+ influx was independently suggested by MnCa2+ influx-induced fura-2 fluorescence quench. In Ca(2 +)-free medium, thapsigargin, an inhibitor of the endoplasmic reticulum Ca(2 +)-ATPase, caused a monophasic [CaCa2+]i increase, after which celecoxib only induced a tiny [CaCa2+]i increase; conversely, pretreatment with celecoxib completely inhibited thapsigargin-induced [CaCa2+]i increases. U73122, an inhibitor of phospholipase C, abolished ATP (but not celecoxib)-induced [CaCa2+]i increases. Overnight incubation with 1 or 10 micro M celecoxib decreased cell viability by 80% and 100%, respectively. These data indicate that celecoxib evokes a [CaCa2+]i increase in renal tubular cells by stimulating both extracellular CaCa2+ influx and intracellular CaCa2+ release and is highly toxic to renal tubular cells in vitro.
Wang
J L
JL
Department of Rehabilitation, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Lin
K L
KL
Chen
W C
WC
Chou
C T
CT
Huang
C J
CJ
Liu
C S
CS
Hsieh
C H
CH
Chang
C H
CH
Huang
J K
JK
Chang
H T
HT
Liu
S I
SI
Hsu
S S
SS
Jan
C R
CR
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D000068579:Celecoxib; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects*; D002470:Cell Survival; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004285:Dogs; D005456:Fluorescent Dyes / Q000378:metabolism; D007684:Kidney Tubules / Q000166:cytology / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000378:metabolism
D016861:Cyclooxygenase Inhibitors; D005456:Fluorescent Dyes; D011720:Pyrazoles; D013449:Sulfonamides; D010738:Type C Phospholipases; D000068579:Celecoxib; D002118:Calcium